News & Politics
Australia has the beginnings of a deal to get access to the Oxford University-AstraZeneca vaccine in development for Covid-19. But what does that mean and how much might it cost? Plus, how the Spanish flu of 1919 affected the economy and how this pandemic is likely to reshape Australian businesses and jobs. Guests: Bonnie Parkinson, Senior Research Fellow, Centre for Health Economics, Macquarie University Simon Kennedy, Partner, McKinsey & Company John Tang, senior economics lecturer, University of Melbourne